Loren Data's SAM Daily™

fbodaily.com
Home Today's SAM Search Archives Numbered Notes CBD Archives Subscribe
FBO DAILY ISSUE OF MAY 27, 2012 FBO #3837
DOCUMENT

A -- RESEARCH ALZHEIMER DISEASE (AD) JUSTIFICATION FOR OTHER THAN FULL AND OPEN COMPETITION - Justification and Approval (J&A)

Notice Date
5/25/2012
 
Notice Type
Justification and Approval (J&A)
 
NAICS
541712 — Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology)
 
Contracting Office
Department of Veterans Affairs;VAMC Providence;MAIL STOP 90C;830 Chalkstone Avenue;Providence RI 02908
 
ZIP Code
02908
 
Solicitation Number
VA24112R0633
 
Archive Date
7/23/2012
 
Point of Contact
John Young
 
E-Mail Address
9-4760
 
Small Business Set-Aside
N/A
 
Award Number
VA241-12-D-0126
 
Award Date
5/24/2012
 
Description
Contractor shall develop practical, relatively inexpensive and widely deployable technology based on near-infrared (NIR) optical spectroscopy to enable definitive diagnoses of early stage dementias and quantitative monitoring of disease progress and response to treatment. In this project, the focus is Alzheimer disease (AD) because of its public health impact and well-characterized neuropathological presentation; dementia with Lewy bodies (DLB) is included to test and develop the power of VA methods to differentiate disorders with overlapping clinical and neuropathological features. The specific objective is to demonstrate the clinical feasibility of assessing human neuropathology in vivo, by means of non-invasive, near-infrared, optical spectroscopy of the human brain. VA aims are: 1) to identify the unique spectroscopic signatures of plaques, tangles, Lewy bodies, nuclei, etc. in diffuse scattering or reflectance spectra of brain tissue; 2) to develop models of light propagation in the adult human head to enable extraction of these unique signatures from spectra of the brain acquired non-invasively; 3) to develop NIR spectroscopy instrumentation for acquiring such spectra in clinical settings and 4) to demonstrate the clinical feasibility of neuropathologic assessment by non-invasive NIR spectroscopy to enable early detection of disease or injury, using patients in the regional Geriatric Research Education and Clinical Center (GRECC) and the Boston University Alzheimer ¿s Disease Center (BUADC).
 
Web Link
FBO.gov Permalink
(https://www.fbo.gov/spg/VA/PrVMAC650/PrVAMC650/VA24112R0633/listing.html)
 
Document(s)
Justification and Approval (J&A)
 
File Name: VA241-12-D-0126 VA241-12-D-0126_1.doc (https://www.vendorportal.ecms.va.gov/FBODocumentServer/DocumentServer.aspx?DocumentId=349164&FileName=VA241-12-D-0126-000.doc)
Link: https://www.vendorportal.ecms.va.gov/FBODocumentServer/DocumentServer.aspx?DocumentId=349164&FileName=VA241-12-D-0126-000.doc

 
File Name: VA241-12-D-0126 P03 JOFOC.PDF (https://www.vendorportal.ecms.va.gov/FBODocumentServer/DocumentServer.aspx?DocumentId=349165&FileName=VA241-12-D-0126-001.PDF)
Link: https://www.vendorportal.ecms.va.gov/FBODocumentServer/DocumentServer.aspx?DocumentId=349165&FileName=VA241-12-D-0126-001.PDF

 
Note: If links are broken, refer to Point of Contact above or contact the FBO Help Desk at 877-472-3779.
 
Record
SN02759392-W 20120527/120525235438-2c2415851d1703572f1c8fb2a81d7f80 (fbodaily.com)
 
Source
FedBizOpps Link to This Notice
(may not be valid after Archive Date)

FSG Index  |  This Issue's Index  |  Today's FBO Daily Index Page |
ECGrid: EDI VAN Interconnect ECGridOS: EDI Web Services Interconnect API Government Data Publications CBDDisk Subscribers
 Privacy Policy  Jenny in Wanderland!  © 1994-2024, Loren Data Corp.